With the two years of advancement of examination, the researchers are now confident that the technology can be transferred to suitable pharma partners for large-scale production
Researchers have kept the technology free of intellectual property rights and are looking for pharmaceutical partners who can take up mass-scale production. Currently, AmB is an injectible drug.
Updated:
Share Article
AAA Researchers at Indian Institute of Technology, Hyderabad (IIT-H) have developed oral solution, which could be mass-produced now, to treat ‘black fungs’ providing huge relief to patients affected with it and doctors finding it hard to treat the patients due to the poor availability of the present medicine.
After two years of advancement of examination, the researchers are now confident that the technology can be transferred to suitable pharma partners for large-scale production.
At present, the Kala-Azar treatment is being used as a treatment for Black and other Fungus in the country and its availability and affordability make it need to allow emergency and immediate trial of this oral drug, argues a team of Prof. Saptarshi Majumdar and Dr. Chandra Shekhar Sharma and their PhD scholars Mrunalini Gaydhane and Anindita Laha, who have been working on the oral solution for the last two years.